You searched for united kingdom - Page 24 of 55 - Labiotech.eu

mab Tiziana foralumab NASH

News and Trends 6 Sep 2017

Tiziana‘s Antibody Formulation Enters Phase IIa Trial for Liver Disease Treatment

Tiziana makes moves towards a €37B market with an oral monoclonal antibody (mAb) formulation to treat non-alcoholic steatohepatitis (NASH) . Tiziana, which has previously developed compounds targeting the second most…

September 6, 2017 - 3 minutesmins - By Alex Dale

f2g fungal infections antifungals aspergillosis

News and Trends 22 Jun 2016

Massive Round: Novel Antifungals get €53M from Top-Notch Investors

F2G has raised €53M to advance its news class of treatments for life-threatening fungal infections, including invasive aspergillosis. The technology has attracted some of the major biotech investors in Europe….

June 22, 2016 - 2 minutesmins - By Denise Neves Gameiro

shutterstock 558600136

News and Trends 25 Jan 2017

Genetically Engineered Mosquitoes will arrive in India to fight Dengue

Oxitec is preparing to start trials testing its solution to reduce the population of disease-transmitting insects in India with its own genetically modified mosquitoes. Oxitec, a spin-out from Oxford University,…

January 25, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

shutterstock 566775526

News and Trends 31 Jan 2017

New British Biotech-Academia Alliance takes on Cardiovascular Disease

Heptares Therapeutics and the University of Cambridge have partnered to investigate a novel target for cardiovascular diseases. Heptares Therapeutics, based in London, develops drugs against historically undruggable G protein-coupled receptors…

January 31, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

ADVERTISEMENT

kidneys kidney disease

News and Trends 4 Nov 2022

EMPA-KIDNEY trial meets primary endpoint in trial for drug to treat chronic kidney disease

A phase 3 clinical trial, EMPA-KIDNEY, met its primary endpoint showing a significant kidney and cardiovascular benefit for adults living with chronic kidney disease (CKD). When treated with Jardiance (empagliflozin), the…

November 4, 2022 - 4 minutesmins - By Liza Laws

Medicxi Novartis Verily EIF Fund

News and Trends 15 Jun 2017

UK-based VC Launches Massive $300M Fund to Fill Gap for Late-Stage Biotech

The UK-based VC Medicxi has raised a massive $300M (€268M) fund backed by Novartis and Google’s Verily to invest in late-stage drug development. After the former life science branch of…

June 15, 2017 - 3 minutesmins - By Melanie De Almeida

genetically modified mosquitoes Oxitec Netherlands

News and Trends 12 Jul 2017

Update: France and the Netherlands deem Oxitec’s GM Mosquitoes Safe for Release

Update (12/07/2017): France’s High Council for Biotechnology (HCB) has also backed the use, with caution, of genetically modified mosquitoes in France. Oxitec expects the report published by the HCB will…

July 12, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Brain Gene Therapy Cover

News and Trends 17 Jul 2018

Gene Therapy Could Prevent Deadly Brain Disease

An international research team used gene therapy to prevent Gaucher disease, a potentially deadly neurodegenerative condition, in mice. The approach could eventually be used to treat human diseases in the…

July 17, 2018 - 3 minutesmins - By Alexander Burik

bristol ieropoulos microbial fuel cell mfc urine

News and Trends 10 May 2016

British Researchers Stack Bacteria to Turn Urine into Electricity

Researchers from Bristol in the UK developed a new design of microbial fuel cells (MFCs), a more efficient way to use wastewater to produce electricity. Want to power your smartphone…

May 10, 2016 - 3 minutesmins - By Denise Neves Gameiro

astrocyte alzheimers disease astronautx blood london

Startup Scout 16 Aug 2019

This Biotech Fights Alzheimer’s Disease by Targeting Support Brain Cells

It’s time to go to London, UK, this week. The UK biotech AstronauTx is developing drugs that could slow the progress of Alzheimer’s disease by aiming at star-shaped cells in…

August 16, 2019 - 4 minutesmins - By Jonathan Smith

cancer

News and Trends 10 Aug 2022

Research discovery may help diagnose and treat cancer and brain disorders

Researchers at Queen’s University Belfast in Northern Ireland have revealed how the pathway of an identified protein could lead to early diagnosis and targeted treatment for several cancers and brain…

August 10, 2022 - 4 minutesmins - By Jim Cornall

RDEB recessive dystrophic epidermolysis bullosa skin blisters

News and Trends 21 Nov 2022

New Replay HSV gene therapy company Telaria to focus on skin diseases

Replay has announced the launch of Telaria, a herpes simplex virus (HSV) gene therapy company targeting rare skin diseases. It is the second of Replay’s product companies to leverage its…

November 21, 2022 - 3 minutesmins - By Jim Cornall